{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-028595","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2024-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.043739+00:00","generated_at":"2026-05-31T18:37:23.929238+00:00","sec_items":["4.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Immix Biopharma replaces auditor KMJ Corbin with Crowe LLP after KMJ partners join Crowe","bullets":["Effective July 17, 2024, Immix dismissed KMJ Corbin & Company LLP and appointed Crowe LLP as its independent registered public accounting firm.","Change follows the partners and professional staff of KMJ joining Crowe; no disagreements or reportable events in fiscal 2022 or 2023.","KMJ's audit reports for the two most recent fiscal years were unqualified and contained no adverse or modified opinions.","KMJ provided a letter agreeing with the dismissal statements, filed as Exhibit 16.1 to this Form 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-028595","json":"https://secwatch.observer/filing/0001493152-24-028595.json","markdown":"https://secwatch.observer/filing/0001493152-24-028595.md","text":"https://secwatch.observer/filing/0001493152-24-028595.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224028595/0001493152-24-028595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224028595/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:37:23.929238+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}